BioWorld MedTech

Dec. 5, 2018

Grail looks to bag SUMMIT, unveils plans for massive U.K. cancer study

Menlo Park, Calif.-based Grail Inc. has caused a stir with its focus on the early detection of cancer. Now, the company is reporting plans to kick off the massive SUMMIT study early next year. Read More

Supreme Court steps in as grammar police for AIA's on-sale bar

Germany weak in digital health, far behind Estonia, Canada, Denmark, Israel

Advisory panel says there is a need for 'bigger and longer' PAS for Optimizer

Study finds cryoablation an effective, in-office treatment for low-risk breast cancer

Israel's E-Motion Medical wins CE mark for novel motility stimulation therapy

Product briefs

Other news to note

Daily M&A

Regulatory front

Appointments and advancements

Financings

BioWorld MedTech's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for April 14, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 14, 2025.

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

3D rendering of glucagon-like peptide 1 (GLP-1)

ADPD 2025: Unlocking GLP-1's potential in neurodegeneration

BioWorld

At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...

Antibodies binding to spike proteins on the surface of SARS-CoV-2 virus

Australian researchers discover new compound to treat long COVID

BioWorld

Researchers have developed a new compound that can prevent long COVID symptoms in mice that could lead to a future drug for the debilitating condition in humans....